Our latest news

https://www.biocentury.com/article/647638

https://www.biocentury.com/article/647638

https://www.asiaone.com/business/clavystbio-launches-translate-life-sciences-breakthroughs-health-impact

https://www.businesstimes.com.sg/garage/temaseks-cla-real-estate-sets-up-life-sciences-investment-company

https://www.biospace.com/article/amgen-to-buy-rodeo-therapeutics-in-721-million-deal/

https://www.fiercebiotech.com/biotech/amgen-drops-55m-upfront-for-rodeo-therapeutics-and-its-prostaglandin-blockers

https://endpts.com/amgen-takes-a-swing-at-regenerative-immunology-with-721m-acquisition-of-rodeo-therapeutics/

https://timmermanreport.com/2021/03/amgen-acquires-rodeo-lean-startup-with-dual-mechanism-for-crohns-colitis/

https://www.genengnews.com/insights/taking-aim-at-peripheral-neuropathy-and-neurodegeneration-targets/

https://www.geekwire.com/2019/seattle-startup-rodeo-therapeutics-raises-cash-regenerative-medicine-treatments/

https://www.prnewswire.com/news-releases/alexandria-venture-investments-launches-the-alexandria-seed-capital-platform-a-novel-and-innovative-seed-stage-life-science-funding-model-and-a-natural-extension-of-alexandria-launchlabs-300578307.html

https://www.geekwire.com/2017/accelerator-corp-announces-new-leadership-renames-accelerator-life-science-partners/

https://timmermanreport.com/2017/12/accelerator-backed-corporate-vcs-spreads-wings-not-boston-sf/

https://www.forbes.com/sites/luketimmerman/2016/01/06/eli-lilly-pfizer-jj-abbvie-join-48m-bet-on-nyc-cancer-drug-startup/?sh=3441ea7c4291

https://www.wsj.com/articles/wanted-biotech-startups-in-new-york-city-1406603189

https://xconomy.com/seattle/2014/01/29/thong-le-takes-over-at-accelerator-with-eyes-on-seattle-and-nyc/

https://www.bizjournals.com/seattle/blog/techflash/2014/01/a-new-approach-to-biotech-investing.html